Inventionmed (WAR:INM) Cyclically Adjusted FCF per Share: zł-0.02 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:INM Inventionmed SA WAR:INM
19 GF Score
Price zł0.10
! 7 Warning Signs
View Full Analysis

What is Inventionmed Cyclically Adjusted FCF per Share?

Inventionmed WAR:INM +2.45% 19 Cyclically Adjusted FCF per Share is zł-0.02 as of Mar. 2026. GuruFocus rates WAR:INM with a GF Score™ of 19/100. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Inventionmed's adjusted free cash flow per share for the three months ended in Mar. 2026 was zł-0.001. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is zł-0.02 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-22), Inventionmed's current stock price is zł0.1045. Inventionmed's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was zł-0.02. Inventionmed's Cyclically Adjusted Price-to-FCF of today is .


Inventionmed  (WAR:INM) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Inventionmed Cyclically Adjusted FCF per Share Related Terms


Inventionmed Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Inventionmed's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventionmed Cyclically Adjusted FCF per Share Chart

Inventionmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.04 -0.03 -0.02 0.00

Inventionmed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 0.00 0.00 -0.02

WAR:INM vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Inventionmed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inventionmed Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inventionmed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Inventionmed's Cyclically Adjusted Price-to-FCF falls into.


WAR:INM
19GF Score
Inventionmed SA WAR:INM
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inventionmed Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Inventionmed's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.001/163.0700*163.0700
=-0.001

Current CPI (Mar. 2026) = 163.0700.

Inventionmed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.000 99.552 0.000
201609 0.000 99.064 0.000
201612 0.000 100.366 0.000
201703 -0.001 101.018 -0.002
201706 0.000 101.180 0.000
201709 0.000 101.343 0.000
201712 0.005 102.564 0.008
201803 -0.001 102.564 -0.002
201806 -0.002 103.378 -0.003
201809 -0.001 103.378 -0.002
201812 -0.001 103.785 -0.002
201903 -0.001 104.274 -0.002
201906 -0.001 105.983 -0.002
201909 -0.001 105.983 -0.002
201912 -0.001 107.123 -0.002
202003 -0.004 109.076 -0.006
202006 0.000 109.402 0.000
202009 -0.002 109.320 -0.003
202012 -0.016 109.565 -0.024
202103 -0.001 112.658 -0.001
202106 -0.018 113.960 -0.026
202109 -0.001 115.588 -0.001
202112 0.034 119.088 0.047
202203 -0.009 125.031 -0.012
202206 -0.020 131.705 -0.025
202209 -0.010 135.531 -0.012
202212 0.013 139.113 0.015
202303 -0.006 145.950 -0.007
202306 -0.022 147.009 -0.024
202309 -0.018 146.113 -0.020
202312 -0.028 147.741 -0.031
202403 0.011 149.044 0.012
202406 0.000 150.997 0.000
202409 -0.002 153.439 -0.002
202412 -0.005 154.660 -0.005
202503 -0.003 157.021 -0.003
202506 -0.001 157.509 -0.001
202509 0.000 158.000 0.000
202512 0.000 158.320 0.000
202603 -0.001 163.070 -0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of zł-0.02 mean?
Inventionmed (WAR:INM) has a Cyclically Adjusted FCF per Share of zł-0.02 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Inventionmed and its competitors.
Is Inventionmed's Cyclically Adjusted FCF per Share too high?
Inventionmed's current Cyclically Adjusted FCF per Share is zł-0.02. Overall, Inventionmed has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Inventionmed's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Inventionmed's Cyclically Adjusted FCF per Share of zł-0.02 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Inventionmed and its competitors. Inventionmed's current Cyclically Adjusted FCF per Share is zł-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inventionmed stock overvalued right now?
Inventionmed (WAR:INM) has a current Cyclically Adjusted FCF per Share of zł-0.02. The current Cyclically Adjusted FCF per Share is zł-0.02. Inventionmed's overall GF Score™ is 19/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Inventionmed (WAR:INM), the current Cyclically Adjusted FCF per Share is zł-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inventionmed Business Description

Address Jana Zamoyskiego 2B Street, Bydgoszcz, POL, 85-063
Inventionmed SA focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology. The company's project consists of TutorDerm, Double immersion, Virtual Syringe, and others.
19GF Score

Get the complete analysis for WAR:INM

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.10
Price